ipriflavone has been researched along with Hyperparathyroidism, Secondary in 2 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugimura, T | 2 |
| Yamagami, S | 1 |
2 other studies available for ipriflavone and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
[The effect of conservative and surgical management for secondary hyperparathyroidism and their problems].
Topics: 24,25-Dihydroxyvitamin D 3; Adult; Arm; Bone and Bones; Bone Density; Calcitonin; Chi-Square Distrib | 1991 |
[Research on the treatment of secondary hyperparathyroidism as a complication of chronic renal failure].
Topics: Acid Phosphatase; Alkaline Phosphatase; Aluminum; Bone Density; Calcitonin; Calcitriol; Drug Adminis | 1991 |